Research on obsessive-compulsive disorder

Current Opinion in Psychiatry

Volumn 16, Issue SUPPL. 2, 2003, Pages

  López Ibor, Juan J ^a   López Ibor, María Ines ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Basal ganglia; Neuroimaging; OCD; Orbitofrontal; Serotonine

Indexed keywords

RADIOISOTOPE; SEROTONIN; SEROTONIN AGONIST;

BASAL GANGLION; BIOLOGICAL MODEL; CLINICAL RESEARCH; COGNITIVE DEFECT; FRONTAL CORTEX; GENETIC ASSOCIATION; HUMAN; ISOTOPE LABELING; MAGNETOENCEPHALOGRAPHY; MOTOR DYSFUNCTION; NERVE CELL NETWORK; NEUROANATOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSESSIVE COMPULSIVE DISORDER; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; REVIEW; SENSORY DYSFUNCTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRUCTURE ACTIVITY RELATION; SYMPTOMATOLOGY;

EID: 0042744827     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001504-200304002-00013     Document Type: Review

References (55)

1. Alfonse X, El Sabio. The Seven Laws. Digital Archives for Spanish Manuscripts and Text [in Spanish]. Madrid: National Library; 1941.
2. Janet P. Les Obsessions et la Psychasténie [in French]. Paris: Alcan; 1903.
3. Esquirol E. Mental diseases seen from a medical, preventive and medico-legal perspective [in French]. Paris: Baillière; 1864.
4. Westphal K. On obsessive representations [in German]. Archiv für Psychiatrie und Nervenkrankheiten 1878; 8:734-750.
5. Meige H, Feindel E. Tics and their treatment. New York: William Wood; 1907.
6. Rasmussen SA, Tsuang MT. Clinical characteristics and family history in DSM-III obsessive-compulsive disorder. Am J Psychiatry 1986; 143:317-322.
7. Carey G, Gottesman IL. Twin and family studies of anxiety, phobic, and obsessive-compulsive disorders. In: Klien DF, Rabking J, editors. Anxiety: new research and changing concepts. New York: Raven Press; 1981. pp. 117-136.
8. Swede SE, Rapoport JL, Cheslow DL, et al. High prevalence of obsessive-compulsive symptoms in patients with Sydenham's chorea. Am J Psychiatry 1989; 146:246-249.
9. Gilles de La Tourette G. Study on a neurological illness characterized by psychomotor abnormalities accompanied by coprolalia and echolalia [in French]. Arch Neurol 1885; 9:19-42, 155-200.
10. Hollander E, Liebowitz MR, DeCaria CM. Conceptual and methodological issues in studies of obsessive-compulsive and Tourette's disorders. Psychiatr Dev 1989; 7:267-296.
11. Crespo-Facorro B, Cabranes JA, López-Ibor Alcocer MI, et al. Regional cerebral blood flow in obsessive-compulsive patients with and without a chronic tic disorder. A SPECT study. Eur Arch Gen Psychiatry Clin Neurosci 1999; 249:156-161.
12. Schilder P. The organic background of obsessions and compulsions. Am J Psychiatry 1983; 94:1397-1414.
13. Conde López V, de la Gándara Martín JJ, Blanco Lozano MI, et al. Minor neurological signs in obsessive-compulsive disorders [in Spanish]. Actas Luso Esp Neurol Psiquiatr Cienc Afines 1990; 18:143-164.
14. Hollander E, De Caria CM, Saud JB, et al. Neurological soft signs in OCD. Arch Gen Psychiatry 1991; 48:278-279.
15. Fernández CE, López-Ibor JJ. Monochlomipramine in the treatment of psychiatric patients resistant to other therapies. Actas Luso Esp Neurol Psiquiatr Cienc 1967; 26:119-147.
16. Yayura-Tobias J, Bebirian R, Neziroglu F, Vagaban H. Obsessive-compulsive disorders as a serotoninergic defect. Res Psychol Psychiatr Behav 1977; 2:279-286.
17. Azmitia EC, Segel M. An autoradiographic analysis of the differential ascending projections of the dorsal and medial raphe nuclei in the rat. J Comp Neurol 1978; 179:641-667.
18. Pearson RC. The contribution of neuroscience: Neuroanatomy. New Oxford Textbook of Psychiatry. Gelder MG, López-Ibor JJ, Andreasen NC, editors. New York: Oxford University Press; 2000. pp. 165-177.
19. Loosen PT, Prange AJ. Serum thyrotropin response to thyrotropin-releasing hormone in psychiatric patients: a review. Am J Psychiatry 1982; 139:405-416.
20. Bauer MS, Whybrow PC. Thyroid hormones and the central nervous system in affective illness: interactions that may have clinical significance. Int Psychiatry 1988; 6:165-175.
21. Charney DS, Goodman WK, Price LH, et al. Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects. Arch Gen Psychiatry 1988; 45:177-185.
22. Zohar J, Mueller EA, Insel TR. Serotonin responsivity in OCD. Arch Gen Psychiatry 1987; 44:946-951.
23. Hollander E, De Caria CM, Nitescu A, et al. Serotoninergic function in OCD. Arch Gen Psychiatry 1992; 49:21-28.
24. Pigott TA, Zohar J, Hill JL, et al. Metergoline blocks the behavioural and neuroendocrine effects of orally administered m-chlorphenylpiperazine in patients with OCD. Biol Psychiatry 1991; 29:418-426.
25. Zohar J, Insel TR, Zohar-Kadoush RC, et al. Serotoninergic responsivity in OCD: effects of clomipramine treatment. Arch Gen Psychiatry 1988; 45:167-172.
26. Hollander E, De Caria C, Gully R, et al. Effects of chronic fluoxetine treatment on behavioural and neuroendocrine responses to metachrophenilpiperazine in OCD. Psychiatry Res 1991; 36:1-17.
27. Hewlett WA, Martin K. Fenfluramine challenges and serotonergic functioning in OCD [abstract]. International Obsessive-Compulsive Disorder Congress; 12-13 March 1993; Capri, Italy.
28. Lopez-Ibor Jr JJ. Serotonin and psychiatric disorders. Int Clin Psychopharmacol 1992; 7 (Suppl 2):5-11.
29. López-Ibor MI, López-Ibor JJ, Cabranes JA. Serotoninergic function in Obsessive-Compulsive Disorder: a neuroendocrinological challenge and cerebral blood flow studies [dissertation, in Spanish]. Madrid: Complutense University; 1994.
30. Lesch KP. Modulation of receptor G-Protein complex function by psychotropic drugs and glucocorticoids: implications for anxiety disorders and depression. Eur Neuropsychopharmacol 1991; 3:340-343.
31. Radja FM, Descarries L, Dewar KM, Reader TA. Serotonin 5HT1 and 5HT2 receptors in adult rat brain after neonatal destruction of nigrostriatal dopamine neurons: a quantitative autorradiographic study. Brain Res 1993; 606:273-285.
32. Saxena S, Rauch SL. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr Clin North Am 2000; 23:563-586.
33. Bench CJ, Friston KJ, Brown RG, et al. Regional cerebral blood flow in depression measured by positron emission tomography: the relationship with clinical dimensions. Psychol Med 1993; 23:579-590.
34. Goodwing G. functional imaging, affective disorder and dementia. Br Med Bull 1996; 52:495-512.
35. Baxter LR, Schwartz JM, Bergman KS, et al. Caudate glucose metabolic rate changes with both drug and behaviour therapy for obsessive-compulsive disorder. Ach Gen Psychiatry 1992; 49:681-689.
36. Baxter Jr LR, Schwartz JM, Mazziotta JC, et al. Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder. Am J Psychiatry 1988; 145:1560-1563.
37. Swede SE, Shapiro MB, Grady CL, et al. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Arch Gen Psychiatry 1989; 46:518-523.
38. Edmoston Y, Austin MP, Prentice N, et al. Uptake of 99 mTC-exametazine shown by single photon emission computerized tomography in obsessive-compulsive disorder compared with major depression and normal controls. Acta Psychiatr Scand 1994; 90:298-303.
39. Lucey JV, Costa DC, Busatto G, et al. Caudate regional cerebral blood flow in obsessive-compulsive disorder, panic disorder and healthy controls on single photon emission computerised tomography. Psychiatry Res 1997; 74:25-33.
40. Rauch SL, Savage CR. Neuroimaging and neuropsychology of the striatum. Psychiatr Clin North Am 1997; 20:741-798.
41. Rubin RT, Villanueva-Meyer J, Ananth J, et al. Regional xenon 133 cerebral blood flow and cerebral technetium 99m HMPAO uptake in unmedicated patients with obsessive-compulsive disorder and matched normal control subjects. Determination by high-resolution single-photon emission computed tomography. Arch Gen Psychiatry 1992; 49:695-702.
42. Malloy P, Rasmussen S, Bradden W, Haler RI. Topographic evoked potential mapping in OCD evidence for frontal lobe dysfunction. Psychiatry Res 1989; 28:63-71.
43. Pujol J, Vendrell P, Deus J, et al. The effect of medial frontal and posterior demyelinating lesions on Stroop interference. Neuroimage 2001; 13:68-75.
44. Flor-Henry P, Yeudall LT, Koles ZJ, Howarth B. Neuropsychological and power spectral EEG investigations of the obsessive-compulsive syndrome. Biol Psychiatry 1979; 14:119-130.
45. Khama S. Obsessive-compulsive disorder: is there a frontal lobe dysfunction? Biol Psychiatry 1988; 24:602-613.
46. Behar BM, Rapoport JL, Berg CJ. Computerized tomography and neuropsychological measures in adolescents with obsessive-compulsive disorder. Am J Psychiatry 1984; 141:363-369.
47. Head D, Bolton D, Hymas N. Deficit in cognitive shifting ability in patients with obsessive-compulsive disorder. Biol Psychiatry 1989; 25:929-937.
48. López-Ibor JJ, Saiz Ruiz J, López-Ibor MI, Viñas R. Obsessive-compulsive disorder and depression. [in Spanish]. Actas Luso Esp Neurol Psiquiat Cienc Afines 1995; 23:97-113.
49. Perani D, Colombo C, Bressi S, et al. [18F]FGD PET study in obsessive-compulsive disorder. A clinical metabolic correlation study after treatment. Br J Psychiatry 1995; 166:244-250.
50. Rauch SL, Savage CR, Alpert NM, et al. The functional neuroanatomy of anxiety: a study of three disorders using positron emission tomography and symptom provocation. Biol Psychiatry 1997; 42:446-452.
51. Rauch SL, Whalen PL, Savage CR, Curran T, et al. Striatal recruitment during an implicit sequence learning task as measured by functional magnetic resonance. Hum Brain Mapping 1997; 5:124-132.
52. Rauch S, Dougherty D, Shin L, et al. Neural correlates of factor analyzed OCD symptom dimensions: a PET study. CNS Spectrums 1998; 3:37-43.
53. Pacella B, Polatin P, Nagler S. Clinical and EEG studies in Obsessive-Compulsive states. Am J Psychiatry 1944; 100:830-838.
54. Behar DM, Fedio P. Quantitative analysis of interictal behaviour in temporal lobe epilepsy. Arch Neurol 1977; 34:454-467.
55. López-Ibor MI, López-Ibor JJ, Ortiz T, et al. Epileptogenic-like activity in OCD. A magnetoencephalography study [abstract]. 12th World Congress of Psychiatry; Yokohama, Japan. 2002.